Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 67

1.

National Survey and Community Advisory Board Development for a Bipolar Disorder Biobank.

Frye MA, Doederlein A, Koenig B, McElroy SL, Nassan M, Seymour LR, Biernacka JM, Daniels AS.

Bipolar Disord. 2015 Aug 20. doi: 10.1111/bdi.12322. [Epub ahead of print]

PMID:
26291791
2.

Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.

Nam HW, Karpyak VM, Hinton DJ, Geske JR, Ho AM, Prieto ML, Biernacka JM, Frye MA, Weinshilboum RM, Choi DS.

Transl Psychiatry. 2015 Aug 18;5:e621. doi: 10.1038/tp.2015.120.

PMID:
26285131
3.

Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses.

Frye MA, McElroy SL, Fuentes M, Sutor B, Schak KM, Galardy CW, Palmer BA, Prieto ML, Kung S, Sola CL, Ryu E, Veldic M, Geske J, Cuellar-Barboza A, Seymour LR, Mori N, Crowe S, Rummans TA, Biernacka JM.

Int J Bipolar Disord. 2015 Dec;3(1):30. doi: 10.1186/s40345-015-0030-4. Epub 2015 Jun 24.

4.

Association between history of psychosis and cardiovascular disease in bipolar disorder.

Prieto ML, McElroy SL, Hayes SN, Sutor B, Kung S, Bobo WV, Fuentes ME, Cuellar-Barboza AB, Crow S, Ösby U, Chauhan M, Westman J, Geske JR, Colby CL, Ryu E, Biernacka JM, Frye MA.

Bipolar Disord. 2015 Aug;17(5):518-27. doi: 10.1111/bdi.12302. Epub 2015 Jun 9.

PMID:
26062406
5.

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.

Biernacka JM, Sangkuhl K, Jenkins G, Whaley RM, Barman P, Batzler A, Altman RB, Arolt V, Brockmöller J, Chen CH, Domschke K, Hall-Flavin DK, Hong CJ, Illi A, Ji Y, Kampman O, Kinoshita T, Leinonen E, Liou YJ, Mushiroda T, Nonen S, Skime MK, Wang L, Baune BT, Kato M, Liu YL, Praphanphoj V, Stingl JC, Tsai SJ, Kubo M, Klein TE, Weinshilboum R.

Transl Psychiatry. 2015 Apr 21;5:e553. doi: 10.1038/tp.2015.47.

6.

The association between sleep disturbances and alcohol relapse: A 12-month observational cohort study.

Kolla BP, Schneekloth T, Mansukhani MP, Biernacka JM, Hall-Flavin D, Karpyak V, Geske J, Frye MA.

Am J Addict. 2015 Jun;24(4):362-7. doi: 10.1111/ajad.12199. Epub 2015 Mar 24.

PMID:
25808396
7.

Assessing the effects of multiple markers in genetic association studies.

Wang X, Biernacka JM.

Front Genet. 2015 Feb 24;6:66. doi: 10.3389/fgene.2015.00066. eCollection 2015. No abstract available.

8.

Clinical risk factors and serotonin transporter gene variants associated with antidepressant-induced mania.

Frye MA, McElroy SL, Prieto ML, Harper KL, Walker DL, Kung S, Chauhan M, Crow S, Sutor B, Galardy CW, Veldic M, Palmer BA, Geske JR, Fuentes M, Cuellar-Barboza AB, Seymour LR, Mori N, Biernacka JM.

J Clin Psychiatry. 2015 Feb;76(2):174-80. doi: 10.4088/JCP.14m09127.

PMID:
25611077
9.

Current landscape, unmet needs, and future directions for treatment of bipolar depression.

Frye MA, Prieto ML, Bobo WV, Kung S, Veldic M, Alarcon RD, Moore KM, Choi DS, Biernacka JM, Tye SJ.

J Affect Disord. 2014 Dec;169 Suppl 1:S17-23. doi: 10.1016/S0165-0327(14)70005-9. Review.

10.

Lack of replication of the GRIN2A-by-coffee interaction in Parkinson disease.

Ahmed I, Lee PC, Lill CM, Searles Nielsen S, Artaud F, Gallagher LG, Loriot MA, Mulot C, Nacfer M, Liu T, Biernacka JM, Armasu S, Anderson K, Farin FM, Lassen CF, Hansen J, Olsen JH, Bertram L, Maraganore DM, Checkoway H, Ritz B, Elbaz A.

PLoS Genet. 2014 Nov 20;10(11):e1004788. doi: 10.1371/journal.pgen.1004788. eCollection 2014 Nov. No abstract available.

11.

Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate.

Karpyak VM, Biernacka JM, Geske JR, Jenkins GD, Cunningham JM, Rüegg J, Kononenko O, Leontovich AA, Abulseoud OA, Hall-Flavin DK, Loukianova LL, Schneekloth TD, Skime MK, Frank J, Nöthen MM, Rietschel M, Kiefer F, Mann KF, Weinshilboum RM, Frye MA, Choi DS.

Transl Psychiatry. 2014 Oct 7;4:e462. doi: 10.1038/tp.2014.103.

12.

Bipolar disorder with comorbid binge eating history: a genome-wide association study implicates APOB.

Winham SJ, Cuellar-Barboza AB, McElroy SL, Oliveros A, Crow S, Colby CL, Choi DS, Chauhan M, Frye MA, Biernacka JM.

J Affect Disord. 2014 Aug;165:151-8. doi: 10.1016/j.jad.2014.04.026. Epub 2014 Apr 19.

13.

Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study.

Mrazek DA, Biernacka JM, McAlpine DE, Benitez J, Karpyak VM, Williams MD, Hall-Flavin DK, Netzel PJ, Passov V, Rohland BM, Shinozaki G, Hoberg AA, Snyder KA, Drews MS, Skime MK, Sagen JA, Schaid DJ, Weinshilboum R, Katzelnick DJ.

J Clin Psychopharmacol. 2014 Jun;34(3):313-7. doi: 10.1097/JCP.0000000000000099. Erratum in: J Clin Psychopharmacol. 2014 Oct;34(5):558.

14.

Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?

Markopoulou K, Biernacka JM, Armasu SM, Anderson KJ, Ahlskog JE, Chase BA, Chung SJ, Cunningham JM, Farrer M, Frigerio R, Maraganore DM.

Parkinsonism Relat Disord. 2014 Jun;20(6):584-9; discussion 584. doi: 10.1016/j.parkreldis.2014.02.021. Epub 2014 Mar 5.

15.

Alpha-synuclein repeat variants and survival in Parkinson's disease.

Chung SJ, Biernacka JM, Armasu SM, Anderson K, Frigerio R, Aasly JO, Annesi G, Bentivoglio AR, Brighina L, Chartier-Harlin MC, Goldwurm S, Hadjigeorgiou G, Jasinska-Myga B, Jeon BS, Kim YJ, Krüger R, Lesage S, Markopoulou K, Mellick G, Morrison KE, Puschmann A, Tan EK, Crosiers D, Theuns J, Van Broeckhoven C, Wirdefeldt K, Wszolek ZK, Elbaz A, Maraganore DM; Genetic Epidemiology of Parkinson's Disease Consortium.

Mov Disord. 2014 Jul;29(8):1053-7. doi: 10.1002/mds.25841. Epub 2014 Feb 27.

16.

A Weighted Random Forests Approach to Improve Predictive Performance.

Winham SJ, Freimuth RR, Biernacka JM.

Stat Anal Data Min. 2013 Dec 1;6(6):496-505.

17.

Detecting Associations between Major Depressive Disorder Treatment and Essential Hypertension using Electronic Health Records.

Pathak J, Simon G, Li D, Biernacka JM, Jenkins GJ, Chute CG, Hall-Flavin DK, Weinshilboum RM.

AMIA Jt Summits Transl Sci Proc. 2014 Apr 7;2014:91-6. eCollection 2014.

18.

Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2.

Winham SJ, Cuellar-Barboza AB, Oliveros A, McElroy SL, Crow S, Colby C, Choi DS, Chauhan M, Frye M, Biernacka JM.

Mol Psychiatry. 2014 Sep;19(9):1010-6. doi: 10.1038/mp.2013.159. Epub 2013 Dec 10.

PMID:
24322204
19.

PDYN rs2281285 variant association with drinking to avoid emotional or somatic discomfort.

Preuss UW, Winham SJ, Biernacka JM, Geske JR, Bakalkin G, Koller G, Zill P, Soyka M, Karpyak VM.

PLoS One. 2013 Nov 6;8(11):e78688. doi: 10.1371/journal.pone.0078688. eCollection 2013.

20.

Integrative gene set analysis: application to platinum pharmacogenomics.

Fridley BL, Abo R, Tan XL, Jenkins GD, Batzler A, Moyer AM, Biernacka JM, Wang L.

OMICS. 2014 Jan;18(1):34-41. doi: 10.1089/omi.2013.0099. Epub 2013 Nov 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk